ProShare Advisors’s Audentes Therapeutics, Inc BOLD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q1 | – | Sell |
-16,002
| Closed | -$958K | – | 1767 |
|
|
2019
Q4 | $958K | Sell |
16,002
-1,425
| -8% | -$85.3K | ﹤0.01% | 811 |
|
|
2019
Q3 | $490K | Buy |
17,427
+550
| +3% | +$15.5K | ﹤0.01% | 992 |
|
|
2019
Q2 | $639K | Sell |
16,877
-1,665
| -9% | -$63K | ﹤0.01% | 917 |
|
|
2019
Q1 | $724K | Buy |
18,542
+166
| +0.9% | +$6.48K | ﹤0.01% | 895 |
|
|
2018
Q4 | $392K | Sell |
18,376
-824
| -4% | -$17.6K | ﹤0.01% | 1035 |
|
|
2018
Q3 | $760K | Sell |
19,200
-462
| -2% | -$18.3K | 0.01% | 942 |
|
|
2018
Q2 | $751K | Buy |
19,662
+633
| +3% | +$24.2K | 0.01% | 943 |
|
|
2018
Q1 | $572K | Buy |
19,029
+508
| +3% | +$15.3K | ﹤0.01% | 1045 |
|
|
2017
Q4 | $579K | Buy |
18,521
+1,823
| +11% | +$57K | ﹤0.01% | 1057 |
|
|
2017
Q3 | $468K | Buy |
16,698
+1,117
| +7% | +$31.3K | ﹤0.01% | 986 |
|
|
2017
Q2 | $298K | Buy |
15,581
+3,324
| +27% | +$63.6K | ﹤0.01% | 1172 |
|
|
2017
Q1 | $209K | Sell |
12,257
-3,020
| -20% | -$51.5K | ﹤0.01% | 1434 |
|
|
2016
Q4 | $279K | Buy |
+15,277
| New | +$279K | ﹤0.01% | 1417 |
|